|
1
|
Lobert VH, Mouradov D and Heath JK:
Focusing the spotlight on the zebrafish intestine to illuminate
mechanisms of colorectal cancer. Adv Exp Med Biol. 916:411–437.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Girard P, Ducreux M, Baldeyrou P, Rougier
P, Le Chevalier T, Bougaran J, Lasser P, Gayet B, Ruffié P and
Grunenwald D: Surgery for lung metastases from colorectal cancer:
Analysis of prognostic factors. J Clin Oncol. 14:2047–2053. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Van Cutsem E, Köhne CH, Hitre E, Zaluski
J, Chang Chien CR, Makhson A, D'Haens G, Pintér T, Lim R, Bodoky G,
et al: Cetuximab and chemotherapy as initial treatment for
metastatic colorectal cancer. N Engl J Med. 360:1408–1417. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang W, Wang PG, Zhan Y and Zhang D:
Prognostic value of p16 promoter hypermethylation in colorectal
cancer: A meta-analysis. Cancer Invest. 32:43–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H,
Gao F, Li DH, Zhao R, Feng GG and Yi J: Detection of aberrant p16
methylation in the serum of colorectal cancer patients. Clin Cancer
Res. 8:188–191. 2002.PubMed/NCBI
|
|
7
|
Merlo A, Herman JG, Mao L, Lee DJ,
Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′ CpG island
methylation is associated with transcriptional silencing of the
tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med.
1:686–692. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shen L, Kondo Y, Rosner GL, Xiao L,
Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR,
Einspahr JG, et al: MGMT promoter methylation and field defect in
sporadic colorectal cancer. J Natl Cancer Inst. 97:1330–1338. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Müller HM, Oberwalder M, Fiegl H,
Morandell M, Goebel G, Zitt M, Mühlthaler M, Ofner D, Margreiter R
and Widschwendter M: Methylation changes in faecal DNA: A marker
for colorectal cancer screening? Lancet. 363:1283–1285. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA. 93:pp.
9821–9826. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deaton AM and Bird A: CpG islands and the
regulation of transcription. Genes Dev. 25:1010–1022. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Costello JF, Frühwald MC, Smiraglia DJ,
Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomäki P,
Lang JC, et al: Aberrant CpG-island methylation has non-random and
tumour-type-specific patterns. Nat Genet. 24:132–138. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Holmquist GP and Ashley T: Chromosome
organization and chromatin modification: Influence on genome
function and evolution. Cytogenet Genome Res. 114:96–125. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jones PA and Takai D: The role of DNA
methylation in mammalian epigenetics. Science. 293:1068–1070. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wistuba II, Mao L and Gazdar AF: Smoking
molecular damage in bronchial epithelium. Oncogene. 21:7298–7306.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chai H and Brown RE: Field effect in
cancer-an update. Ann Clin Lab Sci. 39:331–337. 2009.PubMed/NCBI
|
|
17
|
Coppedè F, Migheli F, Lopomo A, Failli A,
Legitimo A, Consolini R, Fontanini G, Sensi E, Servadio A, Seccia
M, et al: Gene promoter methylation in colorectal cancer and
healthy adjacent mucosa specimens: Correlation with physiological
and pathological characteristics, and with biomarkers of one-carbon
metabolism. Epigenetics. 9:621–633. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Godugu C and Singh M: AlgiMatrix™-based 3D
cell culture system as an in vitro tumor model: An important tool
in cancer research. Methods Mol Biol. 1379:117–128. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hiler D, Chen X, Hazen J, Kupriyanov S,
Carroll PA, Qu C, Xu B, Johnson D, Griffiths L, Frase S, et al:
Quantification of retinogenesis in 3D cultures reveals epigenetic
memory and higher efficiency in iPSCs derived from rod
photoreceptors. Cell Stem Cell. 17:101–115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–459. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bolstad BM, Irizarry RA, Åstrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma CH, Lv Q, Cao Y, Wang Q, Zhou XK, Ye BW
and Yi CQ: Genes relevant with osteoarthritis by comparison gene
expression profiles of synovial membrane of osteoarthritis patients
at different stages. Eur Rev Med Pharmacol Sci. 18:431–439.
2014.PubMed/NCBI
|
|
25
|
Bro R and Smilde AK: Principal component
analysis. Anal Met. 6:2812–2831. 2014. View Article : Google Scholar
|
|
26
|
Rencher AC: Principal component analysis.
Met Multi Anal (Second). 1–407. 2002.
|
|
27
|
Stambolic V, Suzuki A, De La Pompa JL,
Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM,
Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent
cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blyth K, Cameron ER and Neil JC: The RUNX
genes: Gain or loss of function in cancer. Nat Rev Cancer.
5:376–387. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Allen NP, Donninger H, Vos MD, Eckfeld K,
Hesson L, Gordon L, Birrer MJ, Latif F and Clark GJ: RASSF6 is a
novel member of the RASSF family of tumor suppressors. Oncogene.
26:6203–6211. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Atkin WS, Edwards R, Kralj-Hans I,
Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW
and Cuzick J: UK Flexible Sigmoidoscopy Trial Investigators:
Once-only flexible sigmoidoscopy screening in prevention of
colorectal cancer: A multicentre randomised controlled trial.
Lancet. 375:1624–1633. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dai Z, Zheng RS, Zou XN, Zhang SW, Zeng
HM, Li N and Chen WQ: Analysis and prediction of colorectal cancer
incidence trend in China. Zhonghua Yu Fang Yi Xue Za Zhi.
46:598–603. 2012.(In Chinese). PubMed/NCBI
|
|
32
|
Ni S, Peng J, Huang D, Xu M, Wang L, Tan
C, SUN H, Cai S and Sheng W: HER2 overexpression and amplification
in patients with colorectal cancer: A large-scale retrospective
study in Chinese population. Am Society Clin Oncol. 2017.
|
|
33
|
Mu WP, Wang J, Niu Q, Shi N and Lian HF:
Clinical significance and association of RUNX3 hypermethylation
frequency with colorectal cancer: A meta-analysis. Onco Targets
Ther. 7:1237–1245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weisenberger DJ, Siegmund KD, Campan M,
Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D,
Buchanan D, et al: CpG island methylator phenotype underlies
sporadic microsatellite instability and is tightly associated with
BRAF mutation in colorectal cancer. Nat Genet. 38:787–793. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan J, Luo RZ, Fujii S, Wang L, Hu W,
Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, et al: Aberrant
methylation and silencing of ARHI, an imprinted tumor suppressor
gene in which the function is lost in breast cancers. Cancer Res.
63:4174–4180. 2003.PubMed/NCBI
|
|
36
|
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z,
Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al:
The human colon cancer methylome shows similar hypo- and
hypermethylation at conserved tissue-specific CpG island shores.
Nat Genet. 41:178–186. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang JD and Wiemann S: KEGGgraph: A graph
approach to KEGG PATHWAY in R and bioconductor. Bioinformatics.
25:1470–1471. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Arico S, Petiot A, Bauvy C, Dubbelhuis PF,
Meijer AJ, Codogno P and Ogier-Denis E: The tumor suppressor PTEN
positively regulates macroautophagy by inhibiting the
phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol
Chem. 276:35243–35246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Perrone F, Lampis A, Orsenigo M, Di
Bartolomeo M, Gevorgyan A, Losa M, Frattini M, Riva C, Andreola S,
Bajetta E, et al: PI3KCA/PTEN deregulation contributes to impaired
responses to cetuximab in metastatic colorectal cancer patients.
Ann Oncol. 20:84–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y,
Wakasugi T, Takahashi H, Funahashi H, Sato M and Takeyama H: Loss
of PTEN expression is associated with colorectal cancer liver
metastasis and poor patient survival. BMC Gastroenterol. 8:562008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Miyazono K, Maeda S and Imamura T:
Coordinate regulation of cell growth and differentiation by
TGF-beta superfamily and Runx proteins. Oncogene. 23:4232–4237.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wai PY, Mi Z, Gao C, Guo H, Marroquin C
and Kuo PC: Ets-1 and runx2 regulate transcription of a metastatic
gene, osteopontin, in murine colorectal cancer cells. J Biol Chem.
281:18973–18982. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Djos A, Martinsson T, Kogner P and Carén
H: The RASSF gene family members RASSF5, RASSF6 and RASSF7 show
frequent DNA methylation in neuroblastoma. Mol Cancer. 11:402012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
van der Weyden L and Adams DJ: The
Ras-association domain family (RASSF) members and their role in
human tumourigenesis. Biochim Biophys Acta. 1776:58–85.
2007.PubMed/NCBI
|
|
45
|
DesRochers TM, Shamis Y, Alt-Holland A,
Kudo Y, Takata T, Wang G, Jackson-Grusby L and Garlick JA: The 3D
tissue microenvironment modulates DNA methylation and E-cadherin
expression in squamous cell carcinoma. Epigenetics. 7:34–46. 2012.
View Article : Google Scholar : PubMed/NCBI
|
